Analisi del Market Share dell'azienda C-Path per il mese di marzo 2026

Although companies have developed newer methods to test drug safety, these are not globally accepted by the FDA or EMA as proof of safety. This is, in part, because the methods used for testing are often different from company to company. That discrepancy leaves regulatory scientists uncertain about which methods should be preferred. Another key factor is the tests have not, in the past, been independently validated.